Ashwagandha vs Medicinal Mushrooms: Which Is Right for You? An Honest Comparison From a Farm That Doesn’t Sell Ashwagandha

Ashwagandha (Withania somnifera, “Indian ginseng”, a rasayana in Ayurveda and an adaptogen in Western usage) is the root of a nightshade-family plant; medicinal mushrooms — reishi (Ganoderma lucidum, lingzhi), lion’s mane (Hericium erinaceus, yamabushitake), cordyceps and turkey tail (Trametes versicolor) — are a different category altogether: fungal fruiting bodies whose studied compounds are beta-glucans and triterpenes. The short answer: this is not a contest. Ashwagandha has more direct human trials on stress and sleep than any single mushroom; mushrooms are studied for other questions — immune function, cognition, endurance. The right question is not “which is better” but “what am I trying to solve” — and each answer comes with its own caution list. We grow mushrooms and do not sell ashwagandha, so this page would rather be accurate than persuasive.

How do ashwagandha and medicinal mushrooms differ — in mechanism and active compound?

Ashwagandha is a plant root, and its studied compounds — withanolides — are tested mainly against the stress axis (hypothalamus–pituitary–adrenal) and cortisol levels, and, according to MSKCC, possibly through effects on GABA receptors. Medicinal mushrooms are fungal fruiting bodies; their central compound, 1,3/1,6 beta-glucan, is a fiber that the innate immune system recognizes directly through the Dectin-1 receptor — an entirely different mechanism — alongside triterpenes (reishi) and hericenones (lion’s mane).

The difference in mechanism is why “which is better” doesn’t work as a question. Withanolides are studied as a compound that affects the body’s response to stress; beta-glucan is studied as a compound the immune system recognizes — a 2023 study showed that the very structure of fungal beta-glucan determines how the Dectin-1 receptor clusters and signals. These are two different conversations with the body. For the mushroom side in depth, see our article on adaptogens and medicinal mushrooms and the one on the HPA axis and cortisol; they also explain why the word “adaptogen” gets attached to both categories and blurs the difference between them.

What does human research show for ashwagandha on stress and sleep?

That it is the better-studied of the two on this question — and that the research is still small. A controlled trial of 64 adults (300 mg root extract twice daily, 60 days) found a significant drop in stress scores and serum cortisol versus placebo; a 60-participant trial (250 or 600 mg/day, 8 weeks) found lower perceived stress and cortisol; a third (240 mg/day, 60 days) found lower morning cortisol. All were conducted in India, all with a few dozen participants over a few weeks.

This is the first thing worth saying out loud, precisely from someone who sells mushrooms: on stress and sleep, ashwagandha has more direct human trials than any single mushroom. A trial in patients with insomnia (60 participants, 300 mg twice daily, 10 weeks, with actigraphy) found significantly shorter sleep-onset latency and better sleep efficiency than placebo. Two meta-analyses summarize the picture: the 2021 one on sleep (5 trials, 400 participants) found a “small but significant” effect, more pronounced at 600 mg/day and above and over 8 weeks and longer — and added that data on serious adverse effects are limited and more safety data would be needed for long-term use; the 2022 one on stress and anxiety (12 trials, 1,002 participants) found a significant reduction in both — but rated the certainty of evidence as low for both outcomes, because of very large heterogeneity between trials.

In other words: yes, there is something there, and it was measured. And also: the research is small, short, geographically concentrated, and the variation between extracts (different plant parts, different withanolide percentages) makes it hard to extrapolate to the product on the shelf. We’ll come back to that in the quality section — because it is exactly the point we make about mushrooms.

What does research show for medicinal mushrooms — and which question does each mushroom answer?

Not the same question. Reishi was tested in a 132-patient controlled trial in neurasthenia (fatigue and exhaustion) — 8 weeks of a polysaccharide extract reduced the sense of fatigue by 28.3% versus 20.1% on placebo and improved well-being; lion’s mane was tested in three small trials on cognition and mood (4 weeks, 12 weeks, and 28 days in 41 healthy young adults); cordyceps — a 2026 review of adaptogens in sport concludes that its evidence is “preliminary”, while the most consistent evidence is, in fact, for ashwagandha. Turkey tail and reishi are studied around beta-glucan and immunity.

The “which is better” question almost always dissolves the moment you replace it with “what am I trying to solve”. This is the practical division:

Note that the last row is the only one where the two actually meet. In every other row there is no competition — there are two categories answering different questions.

It is worth being precise about study size here too, because we demand it of others: the 2023 lion’s mane trial (41 participants, 1.8 g/day) found faster performance on the Stroop task one hour after a single dose and a “trend” toward lower subjective stress after 28 days (p=0.051) — and the authors themselves write that the findings should be interpreted with caution given the sample size. The 2010 trial (30 women, 4 weeks) measured lower anxiety and depression scores, and the 2019 trial measured cognitive improvement after 12 weeks. That is real research, and it is small. We wrote about lion’s mane and mood separately and at length — “Does Lion’s Mane Support Mood?”. For the immune direction, the mechanism (Dectin-1) and our own numbers are on the beta-glucan page. For all the studies by goal — the research hub, mood and calm filter.

Ashwagandha or reishi for sleep and calm — where do they actually meet?

In one row only: calm. Reishi is the only mushroom in the category that has also been studied against fatigue and well-being in humans, so here the comparison is legitimate — and still not symmetrical. Ashwagandha has direct sleep trials with actigraphy; reishi has one trial in neurasthenia (fatigue), and there is no controlled trial that tested a fruiting-body extract against a diagnosed sleep disorder. Reishi is studied as a modulator, not a sedative.

And there is overlap: reishi has also been studied in the context of stress, so in this case the question is relevant. On the dedicated page we also write what the human research did not find — Reishi for Anxiety and Stress.

This is also why we do not write “reishi instead of ashwagandha”. In the 2005 Chinese trial, 51.6% of those taking the reishi extract were rated “more than minimally improved” versus 24.6% on placebo — a nice number, but it is one trial, on one specific polysaccharide extract, on a fatigue measure rather than a sleep measure. Anyone expecting reishi to do what the ashwagandha trials measured will be disappointed — not because reishi “doesn’t work”, but because it was tested on a different question. How it does fit into an evening, without the “sedative” promise — on the Reishi for Sleep page and the Reishi for Calm and Stress page.

Is there any study that compared ashwagandha with mushrooms head-to-head?

No. We searched PubMed (August 23, 2026) for papers combining ashwagandha or Withania with reishi, Ganoderma, Hericium or Cordyceps and classified as a randomized or clinical trial — four results in total, all reviews and oncology background papers, and not one trial that gave one group ashwagandha and the other a mushroom. The only comparison that exists is indirect: a 2026 review of adaptogens in athletes that rates the evidence for ashwagandha as “most consistent” and for cordyceps as “preliminary”.

This matters to say plainly, because the internet is full of “ashwagandha vs reishi” tables that decide with confidence. Every such table — including ours above — is a map of questions, not the result of a comparison. The difference between the two is the difference between “each has research on a different area” and “X beat Y”. The first can be said honestly; the second, nobody has measured. And a brand that sells one of the two and tells you it is “better” is consulting a study that doesn’t exist. We sell mushrooms, and that is exactly what we will not do.

Who is each one right for — ashwagandha or medicinal mushrooms?

It depends on what is bothering you, not on what sounds better. Acute stress, tension and sleep — that is where ashwagandha has the direct research; focus, endurance, long-term immune support and calm-as-part-of-a-system — that is mushroom territory. And if you are not sure what you are actually looking for — that is not a supplement question, it is a goal question, and we built a quiz for it.

Can you take ashwagandha and medicinal mushrooms together?

Usually yes, because they act through different pathways and no interaction between them is documented — but not on the same day, and not without checking your medication list. The practical recommendation: start with one, give it the time window the research used (8 weeks for ashwagandha, 4–12 weeks for mushrooms), and only then add the other. That way you also know what did what.

Usually yes — they act through different pathways, and there is no known interaction between them. But two things matter: first, when you start two at once it is hard to know what worked. Better to start with one and give it time. Second, ashwagandha is not for everyone — it is not recommended in pregnancy, and requires caution with thyroid conditions and autoimmune diseases. Medicinal mushrooms require their own caution, mainly with blood thinners and immunosuppressant drugs.

In both cases: if you take regular medication — consult a doctor before starting. Neither is a substitute for medical treatment.

One more practical point from the MSKCC monograph: ashwagandha is attributed sedative and GABAergic activity, so anyone taking benzodiazepines, anticonvulsants or barbiturates should avoid it or consult first — and if you combine it with reishi in the evening, remember you are stacking two compounds each studied in the direction of calm. How to time and stack mushrooms with each other — in “When to Take Mushroom Supplements”.

Who shouldn’t take ashwagandha — and what happened in Denmark?

In April 2023 Denmark banned the sale of ashwagandha in food supplements, based on a 2020 risk assessment by the Technical University of Denmark (DTU) that pointed to possible effects on the thyroid and on sex hormones, and to the traditional use of the root as an abortifacient — and concluded that no safe dose could be derived from the existing data. The decision is scientifically contested, and Sweden and Finland have considered following it. It does not mean ashwagandha is dangerous for everyone; it means it has a caution list, and you should know it.

It is only fair to give the other side too: the DTU assessment drew criticism — researchers at the University of Mississippi (National Center for Natural Products Research) published a 2024 review finding the scientific basis for the decision “questionable”, partly because the report did not distinguish root extracts from leaf extracts; and McGill University’s Office for Science and Society wrote that the abortion claim is “not backed by clinical evidence” but by a reference to traditional use. European and US drug regulators did not follow Denmark. What is documented in the medical literature, and not in dispute:

The right tone here is not panic. Most ashwagandha users in the trials reported no significant side effects, and the meta-analyses note this. But “not reported in an 8-week trial” is not “safe for years”, and that is exactly what the sleep meta-analysis writes in its own words. Anyone with a thyroid, liver, pregnancy or sedative-medication background — talks to a doctor before, not after.

Who shouldn’t take medicinal mushrooms?

Anyone on blood thinners or immunosuppressants without consulting, anyone allergic to mushrooms, and anyone looking for an immediate result. The safety profile of medicinal mushrooms in the literature differs from ashwagandha’s — there is no regulatory ban in any Western country and no liver-injury case series — but “different” is not “empty”, and we lay it out with the same seriousness.

The broad rules — who consults before any mushroom supplement, what is known about blood thinners (warfarin, apixaban, rivaroxaban), about immunosuppressants after transplant, and about planned surgery — are in the side-effects guide and the drug-interactions guide. For lion’s mane we built a dedicated monograph-style page, including the few case reports that exist and the online reports of worsened anxiety — “Who Shouldn’t Take Lion’s Mane?”. In pregnancy and breastfeeding we say the same about mushrooms as about ashwagandha: there is not enough research, so consult rather than guess.

How do you check quality — withanolides vs beta-glucan?

By exactly the same principle. For ashwagandha the number is a standardized withanolide percentage — and, per the criticism of the Danish report, also which part of the plant (root or leaf, whose composition differs). For mushrooms the number is beta-glucan measured on the extract, with alpha-glucan (starch) as the test for grain. A product without a number, in either category, asks for trust instead of giving data.

The more important common denominator: in both categories you cannot know what you bought without a number. For ashwagandha it is the withanolide percentage; for mushrooms it is the beta-glucan percentage. A product that does not state a number — whatever the category — is asking you to believe instead of check.

And there is an exact parallel between the two categories that most writers miss: in ashwagandha, the difference between a root extract and a leaf extract is the distinction the Danish report did not make — and because of which, according to its critics, a sweeping conclusion was drawn; in mushrooms, the difference between fruiting body and mycelium-on-grain is the distinction the label does not make — and because of which a product with starch-inflated “polysaccharides” looks rich. In both cases the remedy is the same: a measured number on the material itself, not a word on the label. How to read such a report line by line — in our COA guide; why beta-glucan and not “polysaccharides” — on the beta-glucan page; and the fruiting-body vs mycelium distinction — in “Fruiting Body or Mycelium?”.

What has the research not shown — on both sides?

Ashwagandha: the research is on specific extracts, small, short and mostly Indian, the certainty of evidence was rated low, and there are no long-term safety data. Mushrooms: most research is on extracts rather than a specific commercial product, few large controlled trials, and for cordyceps in particular — preliminary evidence. A comparison page that praises both sides is not a comparison; this is what is missing.

A comparison page that praises both sides is not a comparison. These are the limitations, as they are:

And two notes to add to that table from what we learned along the way: (a) neither category has been tested against the other — every comparison is a map, not a win; (b) in both, the number the research measured (withanolide dose in a trial, beta-glucan in an extract) is not the number the consumer sees, unless the manufacturer bothers to show it. That is why “which is right for me” always comes back to “what can I verify”.

What we are willing to show — and why it matters even if you choose ashwagandha

Four extracts, four open test reports, zero doubt about what is inside. Beta-glucan is measured at TÜV Austria on the finished extract, on the extract’s dry-matter basis, and alpha-glucan (starch) was not detected in any of them — chemical proof that there is no grain. That is the standard we hold ourselves to, and it is exactly the standard worth demanding of an ashwagandha maker: a number, a lab, and a document.

We do not sell ashwagandha, so we have nothing to say about the quality of one maker or another. What we can show is the standard we apply to ourselves — so you have something to compare every product to, in every category. Testing is done at TÜV Austria on the finished extract, per extract:

The full certificates are open, and if you are still weighing which mushroom fits — the matching quiz takes a minute.

And one more difference a plant root cannot offer, worth knowing when you compare: our mushrooms go from harvest to extraction without a drying step — as far as we know, among the very few in the world — followed by a seven-week alcohol extraction. We wrote about that, and why it matters, in “Fresh vs Dried Mushroom Extract”. Ashwagandha root, by its nature, is harvested, dried and milled — there is no fault in that, there is a difference in what can be verified.

What this page does not claim

That mushrooms are “better” than ashwagandha for stress — on the contrary, on stress and sleep ashwagandha has more direct trials, and we said so. That ashwagandha is dangerous — it requires documented caution, which is different. That we tested ashwagandha — we did not. Or that our percentages can be converted to “milligrams per milliliter” — they cannot, because we have no such measurement.

In the same spirit, four boundaries: (a) the entire comparison on this page is a map of research questions, not the result of a comparative trial — because no such trial exists; (b) the doses mentioned (240–600 mg ashwagandha, 1.8 g lion’s mane) are the studies’ doses, not our recommendation — our recommendations, for mushrooms only, are in the dosage guide; (c) the Danish ban is presented together with the criticism of it, because a half-told fact is not a fact; (d) our numbers are about our extracts and them alone. If someone offers you a sharper comparison than this — ask to see the study that compared.

The bottom line

Ashwagandha and medicinal mushrooms are not two answers to the same question — they are answers to different questions, and only in the “calm” row do they meet. On stress and sleep, ashwagandha has more direct trials, small and short as they are; on immunity, cognition and endurance — mushrooms. Neither has been tested against the other. Ashwagandha carries a documented caution list (thyroid, liver, pregnancy, sedatives — and a contested Danish ban); mushrooms — blood thinners and immunosuppressants. And in both, one rule: a product without a measured number asks you to believe. We prefer to show. And if you are not sure what you are looking for — start from the question, not the supplement.

Frequently asked questions

Ashwagandha or reishi for sleep?

Ashwagandha has more direct human research around sleep and stress. Reishi is studied as an adaptogen rather than a sedative, and there is no controlled trial that tested a fruiting-body extract against a diagnosed sleep disorder — we say so on our own page too.

Do you sell ashwagandha?

No. We grow and make mushroom extracts only. We wrote this page because it is a real question people ask, and a fair answer is worth more than ignoring it.

How do I know whether the ashwagandha I bought is good quality?

By exactly the principle we apply to ourselves: look for a standardized active-compound percentage — withanolides in its case — and a lab test you can see. A product that does not publish a number, whatever the category, is asking you to believe instead of check.

Is there any study that compared ashwagandha with medicinal mushrooms directly?

No. A PubMed search (August 2026) found no randomized trial that gave one group ashwagandha and the other an extract of reishi, lion’s mane or cordyceps. Every “X vs Y” table you will see — ours included — is a map of what each has been studied for, not the result of a contest.

Why did Denmark ban ashwagandha, and does that mean it is dangerous?

In April 2023 Denmark banned its sale based on a 2020 risk assessment pointing to possible effects on the thyroid and sex hormones and to traditional use as an abortifacient. The assessment drew scientific criticism (among other things for not distinguishing root from leaf), and European and US regulators did not follow. The practical conclusion: not “dangerous for everyone”, but “has a caution list” — thyroid, liver, pregnancy, sedative medication.

Can I take ashwagandha together with lion’s mane or reishi?

No interaction between them is documented and they act through different pathways, so in most cases yes — but start with one, give it the research’s time window (about 8 weeks), and only then add, so you know what did what. And if you take regular medication — especially sedatives, blood thinners or thyroid medication — consult first.

How long until you feel a difference — with ashwagandha and with mushrooms?

The ashwagandha trials measured outcomes after 8–10 weeks, and the sleep meta-analysis found the effect more pronounced from 600 mg/day and over 8 weeks and longer. The mushroom trials measured after 4, 8 and 12 weeks. In both categories “a few weeks” is the honest description; anyone promising days is ahead of the research.

What is the difference between withanolides and beta-glucan?

Withanolides are steroidal lactones characteristic of ashwagandha and its relatives, and they are the compounds the stress trials dose; 1,3/1,6 beta-glucan is a fiber from the fungal cell wall that the innate immune system recognizes through the Dectin-1 receptor. Each serves as the quality marker of its own category — and in both, the number should appear on a test report, not just on the label.

Scientific sources (peer-reviewed papers and institutional sources)

• Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine, 2012;34(3):255-262. PubMed
• Salve J, Pate S, Debnath K, Langade D. Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study. Cureus, 2019;11(12):e6466. PubMed
• Lopresti AL, Smith SJ, Malvi H, Kodgule R. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study. Medicine (Baltimore), 2019;98(37):e17186. PubMed
• Langade D, Kanchi S, Salve J et al. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study. Cureus, 2019;11(9):e5797. PubMed
• Cheah KL, Norhayati MN, Husniati Yaacob L et al. Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis. PLoS One, 2021;16:e0257843. PubMed
• Akhgarjand C, Asoudeh F, Bagheri A et al. Does Ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials. Phytotherapy Research, 2022. PubMed
• Björnsson HK, Björnsson ES, Avula B et al. Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network. Liver International, 2020. PubMed
• Philips CA, Valsan A, Theruvath AH et al. Ashwagandha-induced liver injury — A case series from India and literature review. Hepatology Communications, 2023;7(10):e0270. PubMed
• Sharma AK, Basu I, Singh S. Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled Trial. Journal of Alternative and Complementary Medicine, 2018. PubMed
• Kamal HI, Patel K, Brdak A et al. Ashwagandha as a Unique Cause of Thyrotoxicosis Presenting With Supraventricular Tachycardia. Cureus, 2022;14(3):e23494. PubMed
• Kumar A, Sah BK, Ahmad F et al. Potential Adverse Effects of Ashwagandha: A Critical Review of Preclinical and Clinical Evidence. Phytotherapy Research, 2026. PubMed
• Książek A. Current Evidence and Practical Considerations for Adaptogen Use in Exercise Recovery, Training Adaptation, and Exercise Performance in Athletes: A Narrative Review. Nutrients, 2026;18(15):2552. PubMed
• Tang W, Gao Y, Chen G et al. A randomized, double-blind and placebo-controlled study of a Ganoderma lucidum polysaccharide extract in neurasthenia. Journal of Medicinal Food, 2005;8(1):53. PubMed
• Docherty S, Doughty FL, Smith EF. The Acute and Chronic Effects of Lion’s Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study. Nutrients, 2023;15(22):4842. PubMed
• Nagano M, Shimizu K, Kondo R et al. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomedical Research, 2010;31(4):231. PubMed
• Anaya EU, Amin AE, Wester MJ et al. Dectin-1 multimerization and signaling depends on fungal β-glucan structure and exposure. Biophysical Journal, 2023. PubMed
• Chen L, Liu X, Zheng K et al. Cordyceps Polysaccharides: A Review of Their Immunomodulatory Effects. Molecules, 2024;29(21):5107. PubMed
• Weiner JD, Hill A, Shen C et al. Identifying immunostimulatory herbal supplements that may flare autoimmune skin diseases: a systematic scoping review. Lupus Science & Medicine, 2025. PubMed
• Memorial Sloan Kettering Cancer Center, About Herbs — Ashwagandha: warnings on pregnancy, sedatives, thyrotoxicosis and liver injury. Monograph
• McGill University, Office for Science and Society. Why did Denmark ban Ashwagandha? (2023). Article
• University of Mississippi News. UM Researchers Review Reasoning for Nordic Ashwagandha Ban (Journal of Ethnopharmacology, 2024). Article

Read next

• Which Mushroom Is Right for Me? A Goal-Based Guide
• Reishi for Anxiety and Stress — what the research shows and doesn’t
• Does Lion’s Mane Support Mood?
• Who Shouldn’t Take Lion’s Mane? Side Effects & Interactions
• When to Take Mushroom Supplements — Morning, Night, and Stacking
• Adaptogens and Medicinal Mushrooms
• Beta-Glucan vs. Polysaccharides: The Number That Actually Matters
• How to Read a Mushroom Supplement COA
• Medicinal Mushrooms by Goal
• Functional Mushrooms — The Complete Guide
• Full lab results

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This page is educational and does not replace medical advice; consult a healthcare professional before starting any supplement, especially if you are pregnant, nursing, have a medical condition, or take medication.